A better cure for cancer – and other illnesses – could already be in existence, hidden right under our noses.

For the second consecutive year, UC San Francisco is co-hosting the Precision Medicine World Conference (PMWC), which is being held in January 2017. Precision Medicine World ConferenceThe annual forum brings together experts to speak about the latest findings across health care, data and biotechnology sectors. When: Jan.

2016 has been a year of growth, partnerships and progress at the Helen Diller Family Comprehensive Cancer Center. Our researchers and clinicians, patients and families, community groups, and government and industry partners continued working to make cancer a manageable disease.  Please take some ...

Nearly half of the patients in a safety net health system who had an abnormal stool-based screening test for colorectal cancer failed to receive the recommended colonoscopy within a year, despite the benefits of an integrated health care system with access to colonoscopy and shared electronic health records, according to researchers at UC San Francisco.

Education by community-based non-professional health workers significantly increased colorectal cancer (CRC) screening rates among mostly non-English-speaking, older Chinese-Americans in San Francisco, according to a study led by researchers at UC San Francisco.

UC San Francisco researchers have developed a new variety of targeting system for chemotherapy drugs based on the unusually high free iron content of many cancer cells — distinct from the protein-bound iron that is common throughout the body’s cells.